Kiniksa Pharmaceuticals International, plc Deferred Income Tax Assets, Net
Kiniksa Pharmaceuticals International, plc (KNSA) had Deferred Income Tax Assets, Net of $193.63 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-04-28
- 2026-03-31: Deferred Income Tax Assets, Net $193.63M.
- 2025-12-31: Deferred Income Tax Assets, Net $198.15M.
- 2025-09-30: Deferred Income Tax Assets, Net $201.29M.
- 2025-06-30: Deferred Income Tax Assets, Net $205.51M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-03-31 | $193.63M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $198.15M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $201.29M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $205.51M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $208.16M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $211.15M 10-K · filed 2026-02-24 |
| 2024-09-30 | $207.99M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $204.35M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $214.92M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $219.28M 10-K · filed 2025-02-25 |
| 2023-09-30 | $193.57M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $203.86M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $184.42M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $185.50M 10-K · filed 2024-02-28 |
| 2022-09-30 | $185.84M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $10.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $3.00K 10-Q · filed 2020-11-05 |
| 2020-03-31 | $5.41M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $4.37M 10-K · filed 2021-02-25 |
| 2019-09-30 | $4.63M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $2.61M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.46M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.22M 10-K · filed 2020-03-05 |